Citation Impact
Citing Papers
Microbial Cellulose Utilization: Fundamentals and Biotechnology
2002 Standout
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Hormone therapy for preventing cardiovascular disease in post-menopausal women
2015
Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma.
1988
Differential effects on bone density of progestogen-only methods for contraception in premenopausal women
1995
Health benefits of physical activity: the evidence
2006 Standout
Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women
1996
Vascular consequences of menopause and hormone therapy: Importance of timing of treatment and type of estrogen
2005
Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD
1998
The Role of Calcitonin in the Development and Treatment of Osteoporosis*
1987
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
1993 Standout
Cardiac calcification in adult hemodialysis patients
2002 Standout
Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review
1990
Coronary heart disease: seven dietary factors
1991 Standout
Effects of an Oral Contraceptive Containing Drospirenone on Bone Turnover and Bone Mineral Density
2005
Postmenopausal hormone therapy and atherosclerotic disease
1994
Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause
2004
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
COPII-coated vesicles: flexible enough for large cargo?
2005 StandoutNobel
Uterine fibroids
2001 Standout
Lipoprotein (a) levels in children and young adults: the influence of physical activity. The Cardiovascular Risk in Young Finns Study
1994
The Danish National Patient Registry: a review of content, data quality, and research potential
2015 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Morbidity in Turner Syndrome
1998
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
Changes in Plasma Lipoprotein and Apolipoprotein Composition in Relation to OralVersusPercutaneous Administration of Estrogen Alone or in Cyclic Association with Utrogestan in Menopausal Women
1991
Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
2007 Standout
LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth factor-I
1997
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
2009 Standout
Effects of short-term transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women
1998 StandoutNobel
A strategy to reduce cardiovascular disease by more than 80%
2003 Standout
Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal Women
1993
Megestrol Acetate-Induced Weight Gain Does Not Negatively Affect Blood Lipids in Elderly Men: Effects of Resistance Training and Testosterone Replacement
2003
Pharmacology of estrogens and progestogens: influence of different routes of administration
2005
Production and Actions of Estrogens
2002 Standout
The Human Plasma Proteome
2002 Standout
Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause
1991
Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
1991 Standout
A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata
1998
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
The Effects of Tibolone in Older Postmenopausal Women
2008
Greater selective uptake by Hep G2 cells of high-density lipoprotein cholesteryl ester hydroperoxides than of unoxidized cholesteryl esters
1993
The Complex Role of Estrogens in Inflammation
2007 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Differential Fermentation of Cellulose Allomorphs by Ruminal Cellulolytic Bacteria
1991
Association of Hormone Replacement Therapy With Hemostatic and Other Cardiovascular Risk Factors
1995
5 Oestrogens and atherosclerotic vascular disease—lipid factors
1993
Hemodynamic Patterns of Age-Related Changes in Blood Pressure
1997 Standout
Atherogenesis: a postprandial phenomenon.
1979 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Cardiovascular Risk Factors During Estrogen-Norethindrone and Cholecalciferol Treatment
1992
Guidelines for the Primary Prevention of Stroke
2014 Standout
Quaternary prevention: reviewing the concept
2018 Standout
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
1989 Standout
Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia
1985
Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 Cells
1997
High-Dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse
1993
Estrogen-induced osteogenesis in intact female mice lacking ERβ
2002 StandoutNobel
The Metabolic Syndrome
2008 Standout
Progressive resistance strength training for improving physical function in older adults
2009 Standout
Rapid reduction and removal of HDL- but not LDL-associated cholesteryl ester hydroperoxides by rat liver perfused in situ
1996
The Role of the Microsomal Triglygeride Transfer Protein in Abetalipoproteinemia
2000
Lipoprotein apoprotein metabolism.
1978
Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy
2003
Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.
1982 Standout
Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
2005
Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions.
1982
High density lipoprotein metabolism.
1984
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Antiinflammatory Properties of HDL
2004 Standout
Effects of Dietary Polyunsaturated and Saturated Fat on the Properties of High Density Lipoproteins and the Metabolism of Apolipoprotein A-I
1978
Works of E. Farish being referenced
Effects of tibolone on lipoprotein(a) and HDL subfractions
1994
A comparison of the effects of lipoproteins of two progestogens used during cyclical hormone replacement therapy
1987
Effects of conjugated equine oestrogens with and without the addition of cyclical norgestrel on serum and urine electrolytes, and the biochemical indices of bone metabolism and liver function
1988
Effects of two continuous hormone therapy regimens on C-reactive protein and homocysteine
2005
Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause
1993
Lipoprotein (a) concentrations in postmenopausal women taking norethisterone.
1991
Changes in the bone and liver isoenzymes of alkaline phosphatase in postmenopausal women being treated with norethisterone
1988
The effects of conjugated equine estrogens plus cyclical dydrogesterone on serum lipoproteins and apoproteins in postmenopausal women
1988
The role of megestrol acetate as an alternative to conventional hormone replacement therapy
2000
Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/ progestogen therapy
1989
EFFECTS OF TREATMENT WITH OESTRADIOL/LEVONORGESTREL ON BONE, LIPOPROTEINS AND HORMONE STATUS IN POSTMENOPAUSAL WOMEN
1989
Lipoprotein(a) and postmenopausal oestrogen
1993
Effects of bilateral oophorectomy on lipoprotein metabolism
1990
Short-term changes in lipoproteins and apoproteins during cyclical oestrogen-progestogen replacement therapy
1991
Ten years post-menopausal hormone replacement therapy — Effect on lipoproteins
1984
Effects of nicardipine on the metabolic responses to food and exercise.
1992
Lipoprotein levels during hormone replacement therapy by vaginal ring pessaries
1984
CALCITONIN AND POSTMENOPAUSAL OSTEOPOROSIS
1984
The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women
1986
Chemical and kinetic study of the lipoproteins in abetalipoproteinaemic plasma.
1978
Effect on lipoproteins of trisequens®, a combined hormone preparation
1984
The effects of hormone implants on serum lipoproteins and steroid hormones in bilaterally oophorectomised women
1984
90136479 Effects of bilateral oophorectomy on lipoprotein metabolism
1990
Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study
2003
The in vitro interaction of human apolipoprotein A-I and high density lipoproteins
1977